Migraine and Depression Share Common Neuropeptide Pathways — CGRP, Substance P, and Neuropeptide Y
Migraine and depression share overlapping biological mechanisms involving CGRP, PACAP, substance P, neuropeptide Y, orexins, serotonin, sex hormones, and immune pathways — explaining their strong bidirectional clinical relationship.
Quick Facts
What This Study Found
Multiple neuropeptide systems (CGRP, PACAP, substance P, neuropeptide Y, orexins) provide overlapping biological substrates for both migraine and depression, explaining their strong bidirectional clinical relationship.
Key Numbers
Migraine patients are 2.5x more likely to develop depression; risk is higher in chronic migraine and migraine with aura; bidirectional relationship.
How They Did This
Comprehensive narrative review of epidemiological, clinical, and molecular evidence linking migraine and depression through shared biological mechanisms.
Why This Research Matters
Treating migraine without addressing depression (and vice versa) leads to poorer outcomes. Understanding shared neuropeptide mechanisms could enable dual-action therapies — drugs that treat both conditions by targeting common pathways like CGRP or PACAP.
The Bigger Picture
The neuropeptide overlap between migraine and depression suggests that anti-CGRP therapies may have unexplored mood benefits, and that depression treatments targeting shared peptide systems could improve migraine. This reframes both conditions as part of a shared neuropeptide dysregulation spectrum.
What This Study Doesn't Tell Us
Narrative review — no new data. Causation vs correlation for shared mechanisms is difficult to establish. Not all migraine patients have depression and vice versa. Individual neuropeptide contributions to each condition are not fully quantified.
Questions This Raises
- ?Do anti-CGRP migraine therapies improve depressive symptoms in comorbid patients?
- ?Could PACAP-targeting drugs treat both migraine and depression simultaneously?
- ?Should psychiatric screening be mandatory for all chronic migraine patients?
Trust & Context
- Key Stat:
- 2.5× depression risk in migraine Shared neuropeptide mechanisms (CGRP, PACAP, substance P, NPY, orexins) explain this strong bidirectional association
- Evidence Grade:
- Moderate evidence — well-supported review integrating epidemiological data with mechanistic evidence from multiple neuropeptide systems.
- Study Age:
- Published in 2024. Integrates latest neuropeptide research including CGRP and PACAP findings.
- Original Title:
- Understanding the Biological Relationship between Migraine and Depression.
- Published In:
- Biomolecules, 14(2) (2024)
- Authors:
- Viudez-Martínez, Adrián, Torregrosa, Abraham B, Navarrete, Francisco, García-Gutiérrez, María Salud
- Database ID:
- RPEP-09449
Evidence Hierarchy
Summarizes existing research on a topic.
What do these levels mean? →Frequently Asked Questions
Why do so many people with migraines also have depression?
Because the two conditions share the same brain chemical pathways. Neuropeptides like CGRP (the target of new migraine drugs), substance P, and neuropeptide Y are involved in both pain processing and mood regulation. When these systems are disrupted, both migraine and depression can result.
Could migraine drugs help with depression too?
Possibly — since CGRP and other neuropeptides targeted by migraine therapies also play roles in mood, treating one condition might benefit the other. Some migraine patients report mood improvements on CGRP antibodies, but this hasn't been formally studied in depression trials yet.
Read More on RethinkPeptides
Cite This Study
https://rethinkpeptides.com/research/RPEP-09449APA
Viudez-Martínez, Adrián; Torregrosa, Abraham B; Navarrete, Francisco; García-Gutiérrez, María Salud. (2024). Understanding the Biological Relationship between Migraine and Depression.. Biomolecules, 14(2). https://doi.org/10.3390/biom14020163
MLA
Viudez-Martínez, Adrián, et al. "Understanding the Biological Relationship between Migraine and Depression.." Biomolecules, 2024. https://doi.org/10.3390/biom14020163
RethinkPeptides
RethinkPeptides Research Database. "Understanding the Biological Relationship between Migraine a..." RPEP-09449. Retrieved from https://rethinkpeptides.com/research/viudez-martinez-2024-understanding-the-biological-relationship
Access the Original Study
Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.
This study breakdown was produced by the RethinkPeptides research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.